Search

Your search keyword '"Giannini, Fabio"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Giannini, Fabio" Remove constraint Author: "Giannini, Fabio"
402 results on '"Giannini, Fabio"'

Search Results

1. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

2. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial

4. Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience

6. Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

12. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype

13. Next-generation sequencing approach to hyperCKemia: A 2-year cohort study

14. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

15. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

18. Using Cluster Analysis to Overcome the Limits of Traditional Phenotype–Genotype Correlations: The Example of RYR1-Related Myopathies

22. A Schematic Approach to Defining the Prevalence of COL VI Variants in Five Years of Next-Generation Sequencing

24. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

25. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

26. Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience

28. Study of total duration of distal compound muscle action potential in demyelinating and axonal Guillain-Barre' syndrome.

29. The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial

31. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis

32. Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

33. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP

34. Different saccadic profile in bulbar versus spinal-onset amyotrophic lateral sclerosis.

35. TBK1 is associated with ALS and ALS-FTD in Sardinian patients

37. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

41. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

43. HFE p.H63D polymorphism does not influence ALS phenotype and survival

44. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

45. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

48. The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial

Catalog

Books, media, physical & digital resources